Warren Buffett ’s Berkshire Hathaway recently trimmed its stake in healthcare provider DaVita.
Berkshire Hathaway (BRKb ) sold 2 million shares of Denver-based DaVita (DVA) on Sept. 17 for $176 million, a per-share price of $88, Barron’s said.
According to a form Buffett’s firm filed with the Securities and Exchange Commission, its DaVita stake now stands at 36.1 million shares, a 31.7% stake. Berkshire Hathaway remains DaVita’s largest shareholder.
The company, which provides kidney dialysis services, has a $10.29 billion market cap; its shares were trading around $85.65 on Wednesday with a price-earnings ratio of 13.31, a price-book ratio of 4.78 and a price-sales ratio of 0.97.
Other health care companies Buffett was invested in as of the end of the second quarter were Teva Pharmaceutical Industries Ltd. (TEVA), Biogen Inc. (BIIB) and Johnson & Johnson (JNJ), Forbes said.
On July 30, DaVita announced its second-quarter results. It posted adjusted earnings of $1.95 per share on $2.8 billion in consolidated revenue, Forbes said.
In a statement, CEO Javier Rodriguez commented on the company's performance in light of the Covid-19 pandemic.
"The continued efforts of our 65,000 teammates in the face of this crisis, while caring for our patients and for each other, are truly inspiring," he said. "They are working tirelessly to embody the DaVita name 'to give life' to over 236,000 patients worldwide."
© 2026 Newsmax Finance. All rights reserved.